Recce Pharmaceuticals Stock

Recce Pharmaceuticals Liabilities

The The Liabilities of Recce Pharmaceuticals (RCE.AX) as of Aug 17, 2026 is 15.47 M AUD. In the previous year, The Liabilities was 15.89 M AUD — a change of -2.69% (lower).

Liabilities

15.47 MAUD

YoY

-2.69%

Last updated:

In 2026, Recce Pharmaceuticals's total liabilities amounted to 15.47 M AUD, a -2.69% difference from the 15.89 M AUD total liabilities in the previous year.

Access this data via the Eulerpool API
Get Free API Key

Recce Pharmaceuticals Stock analysis

What does Recce Pharmaceuticals do? Recce Pharmaceuticals is one of the most popular companies on Eulerpool.

Liabilities Details

Assessing Recce Pharmaceuticals's Liabilities

Recce Pharmaceuticals's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Recce Pharmaceuticals's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing Recce Pharmaceuticals's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

Recce Pharmaceuticals's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in Recce Pharmaceuticals’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about Recce Pharmaceuticals stock

The Liabilities of Recce Pharmaceuticals is 15.47 M AUD in 2026.

The Liabilities of Recce Pharmaceuticals changed from 15.89 M AUD to 15.47 M AUD, representing a -2.69% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of The Liabilities Recce Pharmaceuticals since 2006 – with annual values, charts, and detailed analysis.

The Liabilities's AUD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The Liabilities's Recce Pharmaceuticals historically and in real time.

Access this data via the Eulerpool API
Get Free API Key

Balance Sheet — Recce Pharmaceuticals

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — Recce Pharmaceuticals